Vivakor completes phase I SBIR research grant, submits final report to National Eye Institute

Vivakor, Inc. (OTCBB:VIVK) today announced the completion of its phase one SBIR research grant and submission of its final report to the National Eye Institute of the National Institutes of Health. Research from this grant will be used to improve Vivakor's VivaSight technologies and imaging performance of its Digital Photo Refractor device. Performance parameters of specific components to be used in the device were evaluated to maximize efficiencies of the temporal multiplexing capacity of the VivaSight technologies.

Vivakor Chief Executive Officer and Chief Scientific Officer Dr. Tannin Fuja added this statement to the news: "The high quality of research conducted by Vivakor scientists, as funded through this NIH Grant, will accelerate the development of a superior market-ready VivaSight Device." The company believes the market size of its VivaSight division is estimated to be $50 million annually.